Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | ALPL | P05186 | 1/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
| ▸ | ALPG | P10696 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL264346 | 0.88 | ALOX15 (0.68) | ALOX15MAPTKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL9602821 | 0.85 | ALOX15 (0.59) | ALOX15MAPTKMT2ASMN1; SMN2MEN1 | |
| Ethyl Acetate SCHEMBL29164987 | 0.84 | ALDH1A1 (0.50) | ALOX15MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL27718339 | 0.84 | ALOX15 (0.63) | ALOX15MAPTKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL9327188 | 0.84 | PLA2G4B (0.58) | ALOX15HTT | |
| Acetonitrile SCHEMBL23706321 | 0.81 | ALOX15 (0.55) | ALOX15MAPTKMT2ASMN1; SMN2MEN1 | |
| SCHEMBL4646407 | 0.81 | MAPT (0.51) | MAPTKMT2ASMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL27528801 | 0.81 | MTNR1A (0.53) | MAPTKMT2ASMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL3913184 | 0.81 | PTGS2 (0.58) | MAPTKMT2ASMN1; SMN2MEN1ALDH1A1 | |
| SCHEMBL2723659 | 0.81 | ALOX15 (0.59) | ALOX15MAPTKMT2ASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 782 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725950-A1 | IMPROVED SOLID-PHASE PHOSPHORAMIDITE-SYNTHESIS OF LONG OLIGONUCLEOTIDE MOLECULES | BioSpring Gesellschaft für Biotechnologie mbH (DE) | 2026-04-15 | — | — | EP | claimed |
| EP-4725949-A1 | IMPROVED SOLID-PHASE PHOSPHORAMIDITE-SYNTHESIS OF LONG OLIGONUCLEOTIDE MOLECULES | BioSpring Gesellschaft für Biotechnologie mbH (DE) | 2026-04-15 | — | — | EP | claimed |
| US-20260097383-A1 | SOLID-PHASE PHOSPHORAMIDITE-SYNTHESIS OF LONG OLIGONUCLEOTIDE MOLECULES | BioSpring Gesellschaft für Biotechnologie mbH (DE) | 2026-04-09 | — | — | US | claimed |
| EP-4658396-A1 | BELT REACTOR MANUFACTURING PROCESS FOR OLIGOMER SYNTHESIS | Arrowhead Pharmaceuticals, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-12454613-B2 | Biodegradable resin and film prepared thereby | TORAY INDUSTRIES, INC. (JP) | 2025-10-28 | — | — | US | claimed |
| CN-119461336-A | Modification method of fluorocarbon, modified fluorocarbon and lithium/fluorocarbon battery | 惠州亿纬锂能股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119390744-A | Method for improving purity of long-chain nucleic acid synthesized by solid-phase phosphoramidite triester method and application thereof | 江苏汉凰科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| CN-119340484-A | Electrolyte and fluorocarbon battery | 惠州亿纬锂能股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119008954-A | Additive for positive electrode slurry of lithium ion battery, positive electrode slurry, positive electrode plate and lithium ion battery | 广东金晟新能源股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024163644-A1 | BELT REACTOR MANUFACTURING PROCESS FOR OLIGOMER SYNTHESIS | Arrowhead Pharmaceuticals, Inc. (US) | 2024-08-08 | — | — | WO | claimed |
| US-10590413-B2 | Chiral control | WAVE LIFE SCIENCES LTD. (SG) | 2020-03-17 | — | — | US | claimed |
| EP-2305402-B1 | METHOD FOR PRODUCING SILVER-CONTAINING POWDER AND CONDUCTIVE PASTE USING THE SAME | DAINIPPON INK & CHEMICALS (JP) | 2017-11-29 | — | — | EP | claimed |
| US-20090306400-A1 | CONVERGENT PROCESS FOR THE SYNTHESIS OF TAXANE DERIVATIVES. | HENRI JOHN T | 2009-12-10 | — | — | US | claimed |
| US-20090137790-A1 | METHOD OF CAPPING OLIGONUCLEIC ACID | NIPPON SHINYAKU CO., LTD. (JP) | 2009-05-28 | — | — | US | claimed |
| EP-2017282-A1 | METHOD OF CAPPING OLIGONUCLEIC ACID | Nippon Shinyaku Co., Ltd. (JP) | 2009-01-21 | — | — | EP | claimed |
| EP-2007739-A2 | A CONVERGENT PROCESS FOR THE SYNTHESIS OF TAXANE DERIVATIVES | Tapestry Pharmaceuticals, Inc. (US) | 2008-12-31 | — | — | EP | claimed |
| WO-2007126893-A2 | A CONVERGENT PROCESS FOR THE SYNTHESIS OF TAXANE DERIVATIVES | TAPESTRY PHARMACEUTICALS, INC. (US) | 2007-11-08 | — | — | WO | claimed |
| US-20070225510-A1 | Convergent Process for the Synthesis of Taxane Derivatives | TAPESTRY PHARMACEUTICALS, INC. | 2007-09-27 | — | — | US | claimed |
| EP-0077029-B1 | RENIN INHIBITORY PEPTIDES | MERCK & CO. INC. (US) | 1985-08-21 | — | — | EP | claimed |
| EP-0077029-A2 | Renin inhibitory peptides | MERCK & CO. INC. (US) | 1983-04-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097383-A1 | SOLID-PHASE PHOSPHORAMIDITE-SYNTHESIS OF LONG OLIGONUCLEOTIDE MOLECULES | RNGTT, NSUN2, RNMT | ALOX15 1691/4885MAPT 3290/4885KMT2A 2129/4885 |
| US-20090137790-A1 | METHOD OF CAPPING OLIGONUCLEIC ACID | RNGTT, DUT, ADAR | ALOX15 1412/4885MAPT 4785/4885KMT2A 361/4885 |
| US-20070225510-A1 | Convergent Process for the Synthesis of Taxane Derivatives | DHPS, TSN, EIF5B | ALOX15 3351/4885MAPT 888/4885KMT2A 4296/4885 |
| US-10590413-B2 | Chiral control | RNGTT, POLI, NSUN3 | ALOX15 2726/4885MAPT 3098/4885KMT2A 2211/4885 |
| US-20090306400-A1 | CONVERGENT PROCESS FOR THE SYNTHESIS OF TAXANE DERIVATIVES. | DHPS, TSN, PARP15 | ALOX15 3598/4885MAPT 797/4885KMT2A 4288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.